Skip to main content
Log in

Societal costs of cancer in the EU over €120 billion

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. funded by Pfizer.

References

  1. Leungo-Fernandez R, et al. Economic burden of cancer across the European Union: a population-based cost analysis. Lancet Oncology : 21 Oct 2013. Available from: URL: http://dx.doi.org/10.1016/S1470-2045(13)70442-X

    Google Scholar 

  2. Lyman GH. Counting the costs of cancer care. Lancet Oncology : 21 Oct 2013. Available from: URL: http://dx.doi.org/10.1016/S1470-2045(13)70480-7

    PubMed  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Societal costs of cancer in the EU over €120 billion. PharmacoEcon Outcomes News 690, 10 (2013). https://doi.org/10.1007/s40274-013-0839-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-013-0839-y

Navigation